Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ: XRAY )

14.96 -0.04 (-0.30%)
Streaming Delayed Price Updated: 10:44 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why
Dentsply Sirona's Q1 disappoints with revenue miss at $953M, down 2.6% YoY; adjusted EPS meets expectations at 42 cents. 
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Meets EPS, Misses Revenue for Q1 2024
XRAY stock results show that Dentsply Sirona met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Via Benzinga
Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Via Benzinga
Wednesday Is Your Last Chance To Buy Dentsply Sirona Before The Dividend Payout
Via Benzinga
Expert Ratings for Dentsply Sirona
Via Benzinga
Looking Into Dentsply Sirona's Return On Capital Employed
Via Benzinga
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits
As the day concludes, Dentsply Sirona (NASDAQ:XRAY) is preparing to distribute a dividend payout of $0.14 per share, resulting in an annualized dividend yield of 1.65%. This payout is exclusive to... 
Via Benzinga
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Needham initiated coverage on Dentsply Sirona Inc (NASDAQ: XRAY), citing its third turnaround effort since the 2016 Dentsply-Sirona merger. 
Via Benzinga
3 Dental Supply Stocks You Can Sink Your Teeth Into
Long-term trends and margin improvements are driving growth for dental supply companies. 
Via The Motley Fool
SmileDirectClub Files For Chapter 11 Bankruptcy Just Four Years After $1.35 Billion IPO
SmileDirectClub Inc. (NASDAQ: SDC), a dental aligner manufacturer, has filed for bankruptcy just a few years after its remarkable $1.35 billion IPO. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Baird Maintains Neutral Rating for Dentsply Sirona: Here's What You Need To Know
Via Benzinga
Dentsply Sirona Revises 2023 Guidance On Strong Q1 Earnings
Via Benzinga
Recap: Dentsply Sirona Q1 Earnings
Via Benzinga
Preview: Dentsply Sirona's Earnings
Via Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
The Latest Analyst Ratings for Dentsply Sirona
Via Benzinga
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Dentsply, and Invivyd on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Material Weakness In Internal Control: Dentsply Stock Falls Despite Q2 Beat - What's Going On
Dentsply Sirona Inc (NASDAQ: XRAY) reported Q2 adjusted EPS of $0.51, down 26% from $0.69 a year ago, beating the consensus 
Via Benzinga
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Parexel Announces Updates to Board of Directors
From Parexel International LLC
Via GlobeNewswire
DENTSPLY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating Dentsply Sirona, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
7 Stocks to Kick Out of the S&P 500
While not all bad companies, these S&P 500 stocks to sell don't deserve a spot in the index or your portfolio. 
Via InvestorPlace
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.